Why Attend?

Preliminary Agenda
CLE

Join a diverse group of stakeholders – public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others – for this virtual conference on effectively regulating the broad spectrum of tobacco and nicotine products in the US. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.

Register

Industry & Firms

$1399
  • +$500 for non-members

Non-Profit

$899
  • +$100 for non-members

Government

$899
  • +$100 for non-members

Academic

$899
  • +$100 for non-members

Student

$99
  • full-time students only
REGISTER NOW

FDLI is committed to ensuring the 2020 conference is well attended by all sectors of the tobacco and nicotine products space.  To this end, we are extending our webinar waiver policy to this year’s event.  Full-time faculty of academic institutions and employees of public health advocacy organizations that hold 501(c)(3) status are eligible to apply for a registration waiver. Please email [email protected] for more information.

 

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

 

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

Gold Sponsor

Call For Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this spring. The input received from industry stakeholders helps us plan a timely and relevant program. 

Planning Committee

Issa Abuaita, Al Fakher USA
Scott D. Ballin, Public Health Consultant
James Baumberger, American Academy of Pediatrics
Aruni Bhatnagar, American Heart Association
Tara Lin Couch, EAS Consulting Group, LLC
Michael Cummings, Medical University of South Carolina
Brittani Cushman, Turning Point Brands, Inc.
Stacey Younger Gagosian*, Truth Iniative
Thomas Glynn, Stanford University School of Medicine
Robyn Gougelet, Pinney Associates, Inc.
Ben Haas, Latham & Watkins LLP
Bryan M. Haynes, Troutman Sanders LLP
Dennis Henigan, Campaign for Tobacco-Free Kids
Desmond Jenson, Public Health Law Center – Tobacco Control Legal Consortium
Eshael Johnson, CTP, FDA
Ondrej Koumal, Philip Morris International
Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
Joe Murillo, JUUL Labs
John Marshall, Altria Client Services LLC
Kelley Coleman Nduom, CDER, FDA
Henry Roemer, Specialty Tobacco Council, Inc.
Barry Schaevitz, Fox Rothschild LLP
Jim M. Solyst, Swedish Match North America
Mark J. Vaders, Womble Bond Dickinson (US) LLP